NEW DELHI — With coronavirus cases still climbing, Honduras got tired of waiting to get vaccines through a United Nations program, so the small Central American country struck out on its own, securing the shots through a private deal.
Honduras “cannot wait on bureaucratic processes or misguided decisions” to give citizens “the peace of mind” offered by the COVID-19 vaccine, said Juan Carlos Sikaffy, president of the Honduran Private Business Council, which helped complete the purchase by providing a bank guarantee.
Other nations are getting impatient too. Unlike past disease outbreaks, where less wealthy countries have generally waited for vaccines to be delivered by the U.N. and other organizations, many are now taking matters into their own hands. Experts are increasingly concerned that these go-it-alone efforts could undermine a U.N.-backed program to get COVID-19 shots to the neediest people worldwide.
Countries including Serbia, Bangladesh and Mexico recently began vaccinating citizens through donations or commercial deals — an approach that could leave even fewer vaccines for the program known as COVAX, since rich countries have already snapped up the majority of this year’s supply.
Led by the World Health Organization, a coalition for epidemic preparedness known as CEPI and a vaccine alliance called GAVI, COVAX was created to distribute vaccines fairly.
Mustaqeem De Gama, a diplomat at the South African mission in Geneva, cited “a level of desperation” fueled by spreading virus variants and “the uncertainty of when any COVAX vaccines might arrive.” He doubted that countries that signed up for COVAX “will even get 10 percent of what they require.”
Even if the effort succeeds, COVAX’s stated goal is to vaccinate less than 30 percent of people in poor countries, meaning that governments must seek other sources to get enough shots to achieve herd immunity.
Serbian President Aleksandar Vucic said his country was forced to cut its own deals after watching rich countries scramble for the shots. He criticized nations that, he said, bought more doses than they needed.
“It’s as if they intend to vaccinate all their cats and dogs,” he said.
Although Serbia paid 4 million euros to COVAX last year, it has not yet received any shots and last month began its immunization campaign with vaccines from Pfizer, China’s Sinopharm and Russia.
Recent manufacturing delays in Europe raise concerns about whether drugmakers will be able to fulfill the multiplying orders.
“There are so many deals being signed that I think it’s hard to see how the numbers could possibly add up for all the doses ordered to actually be produced in the foreseeable future,” said Amanda Glassman, a public health expert with the Center for Global Development.
